Drimva

AstraZeneca

Study Physician- Neuroinflammation, Immunology Cell Therapy

$250K–$375K

US - Cambridge Kendall SQ - MA · Full-time · Posted Oct 30, 2026

Experience
Substantive clinical experience in multiple sclerosis; clinical research experience required. No number of years specified.
Education
MD or equivalent; PhD a plus.

About the job

Leads medical design, monitoring, safety decisions, and interpretation for a global, multi-cohort CAR-T clinical study in multiple sclerosis.

What you'll do

  • Oversee medical monitoring and patient safety from eligibility through long-term follow-up, including adverse-event assessment and dose-escalation decisions.
  • Review study data and adjudicate MS events to inform study adaptations and ensure consistent endpoints.
  • Medically review study and regulatory documents, engage investigators, and provide cross-functional medical leadership.

What they ask for

  • MD or equivalent; board certification in neurology; substantive clinical experience in multiple sclerosis.
  • Clinical research experience involving the design or delivery of clinical studies.
  • Knowledge of MS trial methodology and endpoints (EDSS, relapses, MRI), biostatistics principles, and FDA, EMA and ICH GCP requirements.
  • Ability to influence across a matrix and communicate complex decisions clearly, with a track record of delivering results.

Nice to have

  • Biotech or pharmaceutical clinical-development experience, including oversight of industry-sponsored studies.
  • Experience with CAR-T, other cell therapies or B-cell-depleting therapies; early-phase or first-in-human studies, including dose escalation.

Pay

249,827.20 - 374,740.80 USD Annual (base pay)

Tools

CAR-T, EDSS, MRI, FDA, EMA, ICH GCP

Model-written summary · the original posting is authoritative

First seen Oct 31, 2026 · Last verified Nov 6, 2026 (UTC)